Anti AXL pAb (ATL-HPA037422 w/enhanced validation)

Catalog No:
ATL-HPA037422-25
$290.00
Application: WB, IHC 
Clonality: Polyclonal 
Host: Rabbit 
Reactivity: Human 
Protein Description: AXL receptor tyrosine kinase
Gene Name: AXL
Alternative Gene Name: JTK11, UFO
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000002602: 84%, ENSRNOG00000020716: 87%
Entrez Gene ID: 558
Uniprot ID: P30530
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Cognate Antibody/Antigen for Anti AXL pAb (ATL-HPA037422 w/enhanced validation)
Antigen PrEST Antigen AXL (ATL-APrEST78573)
Documents & Links for Anti AXL pAb (ATL-HPA037422 w/enhanced validation)
Datasheet Anti AXL pAb (ATL-HPA037422 w/enhanced validation) Datasheet (External Link)
Vendor Page Anti AXL pAb (ATL-HPA037422 w/enhanced validation) at Atlas

Documents & Links for Anti AXL pAb (ATL-HPA037422 w/enhanced validation)
Datasheet Anti AXL pAb (ATL-HPA037422 w/enhanced validation) Datasheet (External Link)
Vendor Page Anti AXL pAb (ATL-HPA037422 w/enhanced validation)

Citations for Anti AXL pAb (ATL-HPA037422 w/enhanced validation) – 5 Found
A retrospective analysis of the correlation between AXL expression and clinical outcomes of patients with urothelial bladder carcinoma.
Transl Cancer Res. 2019 Jun;8(3):976-984. doi: 10.21037/tcr.2019.06.06.  PubMed
The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesothelioma.
Br J Cancer. 2013 Feb 19;108(3):621-8. doi: 10.1038/bjc.2013.9. Epub 2013 Jan 29.  PubMed
Immunoproteomics using polyclonal antibodies and stable isotope-labeled affinity-purified recombinant proteins.
Mol Cell Proteomics. 2014 Jun;13(6):1611-24. doi: 10.1074/mcp.M113.034140. Epub 2014 Apr 10.  PubMed
The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markers.
Oncotarget. 2015 May 20;6(14):12763-73. doi: 10.18632/oncotarget.3497.  PubMed
Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma.
Br J Cancer. 2019 Mar;120(5):512-521. doi: 10.1038/s41416-018-0373-6. Epub 2019 Feb 15.  PubMed